Picture loading failed.

Anti-AXL therapeutic antibody (Pre-made Enapotamab biosimilar,Whole mAb ADC) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Enapotamab vedotin (HuMax?-AXL-ADC) is an antibody-drug conjugate (ADC) targeted to Axl (from anexelekto, or uncontrolled growth). Axl is a unique RTK that is aberrantly expressed in many solid tumor types and is implicated in tumor cell proliferation, migration, and invasion.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-179-1mg 1mg 3090
GMP-Bios-ab-179-10mg 10mg 21890
GMP-Bios-ab-179-100mg 100mg 148000
GMP-Bios-ab-179-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-AXL therapeutic antibody (Pre-made Enapotamab biosimilar,Whole mAb ADC)
INN Name Enapotamab
TargetAXL
FormatWhole mAb ADC
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2017
Year Recommended2018
CompaniesGenmab
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedSolid tumours
Development Techna